cytarabin fresenius kabi 100 mg/ ml
fresenius kabi norge as - cytarabin - injeksjons-/infusjonsvæske, oppløsning - 100 mg/ ml
provocholine 100 mg
acic europe limited - metakolinklorid - pulver til inhalasjonsvæske til nebulisator, oppløsning - 100 mg
pylclari
curium pet france - piflufolastat (18f) - prostata neoplasmer - diagnostiske radiopharmaceuticals - dette legemidlet er kun til diagnostisk bruk. pylclari is indicated for the detection of prostate-specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high-risk pca prior to initial curative therapy,to localize recurrence of pca in patients with a suspected recurrence based on increasing serum prostate-specific antigen (psa) levels after primary treatment with curative intent. pylclari is indicated for use with positron emission tomography (pet).
flux 0.25 mg f
karo pharma ab (1) - natriumfluorid - sugetablett med sitronsmak - 0.25 mg f
flux 0.25 mg f
karo pharma ab (1) - natriumfluorid - sugetablett med banansmak - 0.25 mg f
flux 0.5 mg f
karo pharma ab (1) - natriumfluorid - sugetablett med banansmak - 0.5 mg f
flux 0.25 mg f
karo pharma ab (1) - natriumfluorid - sugetablett med bringebærsmak - 0.25 mg f
flux 0.5 mg f
karo pharma ab (1) - natriumfluorid - sugetablett med bringebærsmak - 0.5 mg f
flux 0.25 mg f
karo pharma ab (1) - natriumfluorid - sugetablett med peppermyntesmak - 0.25 mg f
flux 0.5 mg f
karo pharma ab (1) - natriumfluorid - sugetablett med peppermyntesmak - 0.5 mg f